STAT News

STAT+: Five biotech updates to read after ESMO this weekend

Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, expected in 2027, according to Moderna CEO Stéphane Bancel.

By STAT News

1 min read
STAT+: Five biotech updates to read after ESMO this weekend
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights